SEI Investments’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$767K Buy
453,763
+377,134
+492% +$670K ﹤0.01% 2481
2025
Q4
$109K Buy
+76,629
New +$112K ﹤0.01% 3001
2024
Q4
Sell
-342,427
Closed -$356K 2736
2024
Q3
$356K Sell
342,427
-12,965
-4% -$17.8K ﹤0.01% 2293
2024
Q2
$615K Sell
355,392
-1,586
-0.4% -$3.19K ﹤0.01% 2086
2024
Q1
$853K Sell
356,978
-8,444
-2% -$20.8K ﹤0.01% 1941
2023
Q4
$1.22M Sell
365,422
-473,695
-56% -$1.27M ﹤0.01% 1807
2023
Q3
$3.14M Sell
839,117
-12,548
-1% -$58K 0.01% 1382
2023
Q2
$3.64M Buy
851,665
+115,146
+16% +$679K 0.01% 1353
2023
Q1
$5.04M Buy
736,519
+59,001
+9% +$458K 0.01% 1183
2022
Q4
$5.37M Buy
677,518
+14,558
+2% +$112K 0.01% 1021
2022
Q3
$6.37M Buy
662,960
+873
+0.1% +$8.83K 0.01% 981
2022
Q2
$4.79M Buy
662,087
+35,993
+6% +$313K 0.01% 1115
2022
Q1
$8.08M Buy
626,094
+88,162
+16% +$1.12M 0.02% 861
2021
Q4
$8.59M Buy
537,932
+193,917
+56% +$3.39M 0.02% 873
2021
Q3
$5.53M Sell
344,015
-14,972
-4% -$219K 0.01% 1028
2021
Q2
$4.96M Sell
358,987
-562
-0.2% -$7.96K 0.01% 1078
2021
Q1
$5.25M Buy
359,549
+45,440
+14% +$771K 0.01% 991
2020
Q4
$5.46M Buy
314,109
+108,329
+53% +$1.93M 0.01% 933
2020
Q3
$3.77M Buy
205,780
+96,528
+88% +$1.8M 0.01% 1002
2020
Q2
$1.95M Buy
109,252
+90,310
+477% +$1.53M 0.01% 1276
2020
Q1
$311K Sell
18,942
-7,516
-28% -$139K ﹤0.01% 1921
2019
Q4
$477K Sell
26,458
-7,116
-21% -$131K ﹤0.01% 1951
2019
Q3
$684K Sell
33,574
-12,870
-28% -$257K ﹤0.01% 1743
2019
Q2
$1.03M Buy
+46,444
New +$807K ﹤0.01% 1594
2018
Q1
Sell
-38
Closed 3483
2017
Q4
$0 Hold
38
﹤0.01% 3347
2017
Q3
$1K Buy
+38
New +$503 ﹤0.01% 3047
2015
Q4
Sell
-9,773
Closed -$196K 2537
2015
Q3
$196K Buy
+9,773
New +$297K ﹤0.01% 1611

Other funds holding CHRS